A Trial of AMG 479, Everolimus (RAD001) and Panitumumab in Patients With Advanced Cancer - QUILT-3.007

Clinical trial NCT01061788 · COMPLETED

Trial details

NCT number: NCT01061788
Sponsor: Jeffrey Clarke
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors, Non-small Cell Lung Cancer

Start date: 2010-04-01
Primary completion: 2018-12-19
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.